PaulHHayashiMD

PubMed

• 177 citations
  ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury.
  Naga P Chalasani, Haripriya Maddur, Mark W Russo, Robert J Wong, K Rajender Reddy> ;The American Journal of Gastroenterology. 2021 May 1
• 10 citations
  Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials.
  J. Hey-Hadavi, Daniel Seekins, Melissa Palmer, Denise Coffey, John Caminis, Sandzhar Abdullaev, Meenal Patwardhan, Haifa Tyler, Ritu Raheja, Ann Marie Stanley, Liliam ...> ;Drug Safety. 2021 Mar 16
• 6 citations
  Roux-en-Y Gastric Bypass Is Associated With Increased Hazard for De Novo Alcohol-related Complications and Liver Disease.
  Hannah P. Kim, Yue Jiang, Timothy M. Farrell, Christine M. Peat, Paul H. Hayashi, Alfred S. Barritt> ;Journal of Clinical Gastroenterology. 2021 Mar 12
• 5 citations
  Medicare/Medicaid Insurance, Rurality, and Black Race Associated With Provision of Hepatocellular Carcinoma Treatment and Survival.
  Andrew M. Moon, Hanna K. Sanoff, YunKyung Chang, Jennifer L. Lund, A. Sidney Barritt, Paul H. Hayashi, Karyn B. Stitzenberg> ;Journal of the National Comprehensive Cancer Network. 2021 Feb 12
• 16 citations
  Liver injury associated with kratom, a popular opioid-like product: Experience from the U.S. drug induced liver injury network and a review of the literature.
  Jawad Ahmad, Joseph A. Odin, Paul H. Hayashi, Robert J. Fontana, Hari S. Conjeevaram, Bharathi Avula, Ikhlas A. Khan, Huiman X. Barnhart, Raj Vuppalanchi, Victor J. Na...> ;Drug and Alcohol Dependence. 2021 Jan 1
• 2 citations
  The Clinical Spectrum and Diagnosis of Oxaliplatin Liver Injury in the Era of Nonalcoholic Fatty Liver Disease.
  Hannah P. Kim, Victor Navarro, Steven Zacks, Joseph A. Odin, David E. Kleiner, Paul H. Hayashi> ;Clinical Gastroenterology and Hepatology. 2021 Oct 1
• 5 citations
  Stereotactic Body Radiation Therapy for Recurrent, Isolated Hepatocellular Carcinoma Lymph Node Metastasis With or Without Prior Liver Transplantation.
  Tyler Walburn, Andrew M. Moon, Paul H. Hayashi, David A. Gerber, Hanna K. Sanoff, Katrina A. McGinty, David M. Mauro, Joel E. Tepper, Kyle Wang> ;Cureus. 2020 Aug 24
• 2 citations
  Ashwagandha as a cause for liver injury
  Helgi Björnsson, Einar Bjornsson, Bharathi Avula, Ikhlas A. Khan, Jon G. Jonasson, Marwan Ghabril, Paul H. Hayashi, Victor J. Navarro> ;Liver International. 2020 May 31
• 1 citations
  Large Cell Change in a Small Liver: A Histological Clue to Short Telomere Syndromes?
  Steven M Johnson, Katrina A. McGinty, Paul H. Hayashi, Eizaburo Sasatomi> ;Hepatology. 2020 Apr 15
• 6 citations
  Significant Medical Comorbidities Are Associated With Lower Causality Scores in Patients Presenting With Suspected Drug-Induced Liver Injury.
  Marwan Ghabril, Jiezhun Gu, Lindsay Yoder, Laura Corbito, Lara Dakhoul, Amit Ringel, Christian D. Beyer, Raj Vuppalanchi, Huiman X. Barnhart, Paul H. Hayashi, Naga Cha...> ;Clinical and Translational Gastroenterology. 2020 Apr 1
• 38 citations
  Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network.
  Helgi Björnsson, Einar Bjornsson, Bharathi Avula, Ikhlas A. Khan, Jon G. Jonasson, Marwan Ghabril, Paul H. Hayashi, Victor J. Navarro> ;Liver International. 2020 Feb 11
• 25 citations
  Development and Validation of a Model Consisting of Comorbidity Burden to Calculate Risk of Death Within 6 Months for Patients With Suspected Drug-Induced Liver Injury
  Marwan Ghabril, Jiezhun Gu, Lindsay Yoder, Laura Corbito, Amit Ringel, Christian D. Beyer, Raj Vuppalanchi, Huiman X. Barnhart, Paul H. Hayashi, Naga Chalasani> ;Gastroenterology. 2019 Nov 1
• 24 citations
  Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis
  Natasha Kamal, Christopher Koh, Niharika Samala, Robert J. Fontana, Andrew Stolz, Francisco Durazo, Paul H. Hayashi, Elizabeth J. Phillips, Tongrong Wang, Jay H. Hoofn...> ;Hepatology International. 2019 Aug 7
• 33 citations
  Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors.
  Andrew Stolz, Victor Navarro, Paul H. Hayashi, Robert J. Fontana, Huiman X. Barnhart, Jiezhun Gu, Naga Chalasani, Maricruz Vega, Herbert L. Bonkovsky, Leonard B. Seeff...> ;Alimentary Pharmacology & Therapeutics. 2019 May 1
• 22 citations
  Marijuana Consumption in Liver Transplant Recipients.
  Pablo Serrano Rodriguez, Paula D. Strassle, Alfred S. Barritt, Randall Watkins, David A. Gerber, Paul H. Hayashi, Chirag S. Desai> ;Liver Transplantation. 2019 May 1
• 2 citations
  Letter to the Editor: Proton Pump Inhibitors in Cirrhosis: A Marker of Morbid Conditions or a Cause of Mortality?
  Andrew M. Moon, Paul H. Hayashi, A. Sidney Barritt> ;Hepatology. 2019 Aug 1
• 6 citations
  Importance of Hepatitis C Virus RNA Testing in Patients with Suspected Drug-Induced Liver Injury
  Jawad Ahmad, K. Rajender Reddy, Hans L. Tillmann, Paul H. Hayashi, Naga Chalasani, Robert J. Fontana, Victor J. Navarro, Andrew Stolz, Huiman X. Barnhart, Gavin Cloher...> ;Digestive Diseases and Sciences. 2019 Mar 29
• 32 citations
  Charges for Alcoholic Cirrhosis Exceed All Other Etiologies of Cirrhosis Combined: A National and State Inpatient Survey Analysis
  A. Sidney Barritt, Yue Jiang, Monica Schmidt, Paul H. Hayashi, Ramon Bataller> ;Digestive Diseases and Sciences. 2019 Jan 23
• 1 citations
  Correction: Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group.
  Herbert L Bonkovsky, Huiman X Barnhart, David M Foureau, Nury Steuerwald, William M Lee, Jiezhun Gu, Robert J Fontana, Paul H Hayashi, Naga Chalasani, Victor M Navarro...> ;Plos One. 2019 Jan 1
• 13 citations
  Sclerosing Cholangitis-Like Changes on Magnetic Resonance Cholangiography in Patients With Drug Induced Liver Injury.
  Jawad Ahmad, Simona Rossi, Shuchi K. Rodgers, Marwan Ghabril, Robert J. Fontana, Andrew Stolz, Paul H. Hayashi, Huiman X. Barnhart, D Kleiner, Einar S. Bjornsson> ;Clinical Gastroenterology and Hepatology. 2019 Mar 1
• 14 citations
  Long-Term Outcomes After Drug-Induced Liver Injury
  Paul H. Hayashi, Einar Bjornsson> ;Current Hepatology Reports. 2018 Jul 2
• 3 citations
  Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immu...
  Anna S Griffith, Paul H Hayashi, Lauren M. B. Burke, Autumn J McRee> ;Journal of Hepatocellular Carcinoma. 2018 May 31
• 37 citations
  Identification and Characterization of Fenofibrate-Induced Liver Injury
  Jawad Ahmad, Joseph A. Odin, Paul H. Hayashi, N. Chalasani, Robert J. Fontana, Huiman X. Barnhart, Elizabeth T. Cirulli, D Kleiner, Jay H. Hoofnagle> ;Digestive Diseases and Sciences. 2017 Nov 8
• 23 citations
  Trends in Characteristics of Patients Listed for Liver Transplantation Will Lead to Higher Rates of Waitlist Removal Due to Clinical Deterioration.
  Zinan Yi, Maria E. Mayorga, Eric S. Orman, Stephanie B. Wheeler, Paul H. Hayashi, A. Sidney Barritt> ;Transplantation. 2017 Oct 1
• 81 citations
  Death and liver transplantation within 2 years of onset of drug-induced liver injury.
  Paul H. Hayashi, Don C. Rockey, Robert J. Fontana, Hans L. Tillmann, Neil Kaplowitz, Huiman X. Barnhart, Jiezhan Gu, Naga Chalasani, K. Rajender Reddy, Averell H. Sher...> ;Hepatology. 2017 Oct 1
• Join now to see all

Journal Articles

• DILIN Network Idiosyncratic Drug-Induced Liver Injury Is Associated With Substantial Morbidity and Mortality Within 6 Months From Onset  
  Fontana RJ, Hayashi PH, Gu J, Reddy KR, Barnhart H, Watkins PB, Serrano J, Lee WM, Chalasani N, Stolz A, Davern T, Talwakar JA, Gastroenterology, 1/27/2014
• Reliability of causality assessment for drug, herbal and dietary supplement hepatotoxicity in the Drug Induced Liver Injury Network (DILIN)  
  Hayashi PH, Barnhart HX, Fontana RJ, Chalasani N, Davern TJ, Talwalkar JA, Reddy KR, Stolz AA, Hoofnagle JH, Rockey DC, Liver International, 1/24/2014
• ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury  
  Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ, Am J Gastroenterol, 1/17/2014
• Paracentesis in Patients Hospitalized with Cirrhosis and Ascites is Associated with a Reduction in Mortality  
  Orman ES, Hayashi PH, Bataller R, Barritt AS, Clinical Gastroenterology and Hepatology, 1/1/2014
• Hepatic Histologic Findings in Suspected Drug-Induced Liver Injury: Systematic Evaluation and Clinical Associations  
  Kleiner DE, Chalasani NP, Lee WM, Fontana RJ, Bonkovsky HL, Watkins PB, Hayashi PH, Davern TJ, Navarro V, Reddy R, Talwalkar JA, Stolz A, Gu J, Barnhart H, Hoofnagle J..., Hepatology, 1/1/2014
• Decreasing inpatient mortality and increasing palliative care for hospitalized cirrhotic patients in the US  
  Schmidt M, Barritt AS, Orman ES, Hayashi PH, Gastroenterology, 1/1/2014
• Clinical features, diagnosis, and natural history of drug-induced liver injury  
  Hayashi PH, Fontana RJ, Semin Liv Dis, 1/1/2014
• Slow but steady progress in a field with many knowledge gaps  
  Chalasani N, Hayashi PH, Semin Liver Dis, 1/1/2014
• Liver adenomatosis: serial investigation on MRI  
  Srirattanapong S, Angthong W, Kim BS, Hayashi PH, Gerber DA, Woosley JT, Peacock J, Ranatunga A, Semelka RC, Abdominal Imaging, 1/28/2013
• Declining Liver Utilization for Transplant in the United States and the Impact of Donation after Cardiac Death  
  Orman ES, Barritt AS, Wheeler SB, Hayashi PH, Liver Transplantation, 1/1/2013
• Local access to subspecialty care influences the odds of receiving a liver transplant  
  Barritt AS, Telloni SA, Potter CW, Gerber DA, Hayashi PH, Liver Transplantation, 1/1/2013
• Screening for hepatocellular carcinoma in a Medicaid cirrhotic population  
  Palmer L, Kappelman MD, Porter CQ, Sandler RS, Hayashi PH, Journal of Clinical Gastroenterology, 1/1/2013
• Outcomes of patients with elevated alpha-fetoprotein levels and initial negative findings at MRI imaging  
  Kim BS, Hayashi PH, Kim SH, Angthong W, Srirattanapong S, Woosley JT, Semelka RC, Radiology, 1/1/2013
• Presntation and Outcomes with Clinically Apparent Interferon Beta Hepatotoxicity  
  Fontana RJ, Hayashi P, Bonkovsky HL, Kleiner DE, Kochhar S, Gu J, Ghabril M, Digestive Disease Sciences, 1/1/2013
• Liver injury from tumor necrosis factor-alpha-antagonists: analysis of 34 cases  
  Ghabril M, Bonkovsky HL, Kum C, Davern T, Hayashi PH, Kleiner DE, Serrano J, Rochon J, Fontana RJ, Bonacini M, US DILIN, Clinical Gastroenterology and Hepatology, 1/1/2013
• Nonsteroidal Anti-inflammatory Drug Use, Chronic Liver Disease, and Hepatocellular Carcinoma  
  Orman ES, Hayashi PH, Journal of the National Cancer Institute, 1/1/2013
• Liver Transplantation in 2013: Challenges and Controversies  
  Jones PD, Hayashi PH, Barritt AS, Minerva Gastroenterology Dietology, 1/1/2013
• The Impact of Nighttime and Weekend Liver Transplants on Graft and Patient Outcomes  
  Orman ES, Hayashi PH, Gerber DA, Barritt AS, Liver Transplantation, 1/1/2012
• Outcomes of Deceased and Living Donor Liver Transplant Recipients with Hepatocellular Carcinoma: Results of the A2ALL Cohort  
  Kulik LM, Fisher RA, Rodrigo DR, Brown RS, Freise CE, Shaked A, Everhart JE, Everson GT, Hong JC, Hayashi PH, Berg CL, Lok AS, American Journal of Transplantation, 1/1/2012
• Sinusoidal C4d Deposits in Liver Allografts Indicate an Antibody-Mediated Reponse: Diagnostic Considerations in the Evaluation of Liver Allografts  
  Kozlowski T, Andreoni K, Schmitz, Hayashi PH, Nickeliet V, Liver Transplantation, 1/1/2012
• Liver injury in the elderly due to fluoroquinolones: should they be avoided?  
  Hayashi PH, Chalasani NP, Canadian Medical Association Journal, 1/1/2012
• Role of acute hepatitis E in suspected drug-induced liver injury  
  Davern TJ, Naga Chalasani N, Fontana RJ, Hayashi PH, Kleiner DE, Engle RE, Purcell RH, Gu J, Serrano J, Hoofnagle JH for the DILIN, Gastroenterology, 1/1/2011
• Focal Fat Masquerading as Malignancy in the Liver Graft of a Post-Transplant Patient: A Case Report  
  Patrick CM, Hayashi PH, Greene KG, Semelka RC, Barritt AS, Digestive Disease Sciences, 1/1/2011
• Laboratory test patterns after living liver donation  
  Trotter JF, Gillespie BW, Terrault NA, Abecassis MM, Merion RM, Brown RS Jr, Olthoff KM, Hayashi PH, Berg CL, Fisher RA, Everhart JE, Liver Transplantation, 1/1/2011
• Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies  
  Kozlowski T, Rubinas T, Nickeleit V, Woosley J, Schmitz J, Collins D, Hayashi PH, Passannante A, Andreoni K, Liver Transplantation, 1/1/2011
• Join now to see all

Books/Book Chapters

• Transplantation of the Liver 
  Chapter: Adult Living Donor and Recipient Evaluation and Selection. 
  Trotter JF, Hayashi PH, Kam IEditors: Busuttil RW, Klintmalm GB.W.B. Saunders, Philadelphia, PAEdition 2nd,2005
• Pocket ICU Management 
  Chapter: Hepatopulmonary Syndrome. 
  Hayashi PHEditors: Farmer JC, Wall MH.PocketMedicine.com, Inc., New York, NY2003
• Pocket ICU Management 
  Chapter: Ascites and Hepatorenal Syndrome. 
  Hayashi PHEditors: Farmer JC, Wall MH.PocketMedicine.com, Inc., New York, NY2003

Abstracts/Posters

• Poor Adherence to Isoniazid (INH) Monitoring Guidelines is Common in Cases of INH Hepatotoxicity and is Associated with More Severe Liver Injury: Experience of The Dr...
  Hayashi PH, Davern TJ, Fontana RJ, Chalasani NP, Stolz AA, Talwalker JA, Navarro VJ, Lee WM, Kleiner DE, Gu J, Hoofnagle JH for the Drug Induced Liver Injury Network (..., 1/1/2013
• Decreased Inpatient Mortality Amongst U.S. Cirrhotic Patients from 2002-2010: Evidence of Improving Inpatient Cirrhosis Care. Poster Presentation
  Schmidt M, Barritt AS, Orman ES, Hayashi PH, 1/1/2013
• Primary Care Physician Attitudes and Practices Regarding Screening for Hepatocellular Carcinoma. Poster Presentation
  McGowan CE, Luong MT, Hayashi PH, 1/1/2013
• Statins are Associated with a Decreased Risk of Variceal Bleeding in Compensated Cirrhosis. Poster Presentation
  Orman ES, Martin C, Kappelman M, Hayashi PH, Long M, 1/1/2013
• 20-year Forecast of Deceased Donor Liver Availability and Utilization in the United States Using Discrete Event Simulation. Poster Presentation
  Orman ES, Wheeler S, Diaz HT, Hayashi PH, Mayorga M, Barritt AS, 1/1/2013
• Use of Hemodialysis for Cirrhotic Patients with Acute Kidney Injury in the US: Trends from 2002-2010. Poster Presentation
  Schmidt M, Barritt AS, Hayashi PH, Orman ES, 1/1/2013
• Underutilization of statins in patients with hepatitis C and compensated cirrhosis.
  Orman ES, Long MD, Martin C, Kappelman MD, Hayashi PH, Hepatology; AASLD Annual Meeting, 1/1/2012
• Reliability of the Drug Induced Liver Injury Network (DILIN) Expert Opinion Process in the Diagnosis of DILI.
  Hayashi PH, Barnhart HX, Fontana RJ, Chalasani NP, Davern TJ, Talwalkar J, Reddy KR, Stolz A, Hoofnagle JH, Rockey DC, Hepatology; AASLD Annual Meeting, 1/1/2012
• The number of grafts available for liver transplantation is decreasing as a result of increasing donor age metabolic syndrome and donation after cardiac death.
  Orman ES, Hayashi PH, Barritt AS, Gastroenterology; Oral presentation, DDW, 1/1/2012
• Local access to subspecialty care influences the odds of receiving a liver transplant.
  Barritt AS, Telloni S, Potter C, Gerber DA, Hayashi PH, Hepatology; AASLD Annual Meeting, 1/1/2011
• Protocol algorithm for the cardiovascular risk assessment of liver transplant candidates significantly lowers post-transplant cardiac complications.
  Shadan A, Stalls C, Mahmood S, Gerber D, Stouffer GA, Hayashi PH, Hepatology; AASLD Annual Meeting, 1/1/2011
• Baseline, donor, and on-treatment predictors of sustained virologic response in patients treated for recurrent hepatitis C following orthotopic liver transplant: suban...
  Gordon Fredric, Poordad F, Neff GW, Mukherjee S, Barnard G, Barnes DS, Koch A, Hayashi PH, Lucey MR, Kulik LM, Smith AD, Olyaee MS, Mantry P, Chaudhri EI, Pedicone L, Hepatology; AASLD Annual Meeting, 1/1/2010
• Long-term health related quality of life after liver donation in the adult to adult living donor liver transplantation cohort (A2ALL) study.
  Ladner D, Butt Z, Gillespie BW, Tong L, Brown RS, Freise CE, Hayashi PH, Hong JC, Ashworth A, Berg CL, Everson GT, Shaked A, Hepatology; AASLD Annual Meeting, 1/1/2010
• HCC recurrence and survival in living donor liver transplant compared to deceased donor liver transplant: results of the adult to adult liver donor transplant (A2ALL) ...
  Kulik L, Fisher RA, Lok AS, Rodrigo DR, Brown RS, Freise CE, Shaked A, Everson GT, Hong JC, Hayashi PH, Berg CL, Hepatology; AASLD Annual Meeting, 1/1/2010
• Screening for hepatocellular carcinoma in a Medicaid cirrhotic population: opportunities for improvement.
  Palmer L, Kappelman MD, Porter CQ, Sandler RS, Hayashi PH, Gastroenterology; DDW, 1/1/2010
• The influence of NAFLD and its associated comorbidities on liver transplant outcomes. Poster Presentation
  Barritt AS, Kozlowski T, Gerber D, Hayashi PH, DDW, 1/1/2010
• Antibody to hepatitis E in patients with suspected drug-induced liver injury.
  Davern TJ, Chalasani NP, Fontana RJ, Hayashi PH, Kleiner DE, Engle RE, Purcell RH, Rochon J, Serrano J, Hoofnagle JH, Hepatology; AASLD Annual Meeting, 1/1/2009
• Benefits of living donor liver transplantation according to MELD score and diagnosis of hepatocellular carcinoma.
  Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE, Hepatology; AASLD Annual Meeting, 1/1/2009
• Liver regeneration in donors and recipients in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL).
  Olthoff KM, Emond JC, Trotter JF, Tong L, Merion RM, Baker TB, Berg CL, Fisher RA, Freise CE, Hayashi PH, Hong J, Everhart JE, American Journal of Transplantation; ATC Annual Meeting, 1/1/2009
• Long-term follow-up of laboratory values in right hepatic lobe liver donors following donation: the A2ALL experience.
  Jensen GS, Terrault N, Blei AT, Merion RM, Gillespie BW, Everhart JE, Brown RS, Olthoff KM, Hayashi PH, Berg CL, Fisher RA, Trotter JF, Hepatology; AASLD Annual Meeting, 1/1/2008
• Complications after living liver donation: a prospective, multicenter report.
  Abecassis MM, Olthoff KM, Trotter JF, Fisher RA, Merion RM, Tong L, Samstein B, Busuttil RW, Freise CE, Hayashi PH, Berg CL, Hepatology; Transplant Plenary I, AASLD Annual Meeting, 1/1/2008
• Predicting deceased donor age and obesity trends and their effects on liver transplantation growth.
  Hayashi PH, Axelrod DA, Schnitzler MS, Hepatology; AASLD Annual Meeting, 1/1/2008
• A prospective study of the reliability of the RUCAM for assessing causality in drug-induced liver injury.
  Rochon J, Seeff LB, Fontana RJ, Liangpunsakul S, Hayashi PH, Davern TJ, McHutchison JG, Hepatology; AASLD Annual Meeting, 1/1/2007
• Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation.
  Merion RM, Shearon TH, Berg CL, Everhart JE, Abecassis MM, Shaked A, Fisher RA, Trotter JF, Brown RS, Terrault N, Hayashi PH, Ghobrial RM, Hepatology; Transplant Plenary I, AASLD Annual Meeting, 1/1/2007
• Regional differences in deceased donor liver utilization and organ wastage.
  Hayashi PH, Salvalaggio PR, Axelrod DA, Schnitzler M, Hepatology; Transplant Plenary I, AASLD Annual Meeting, 1/1/2007
• Join now to see all

Lectures

• Update in Cirrhosis Care and Transplantation 
  1/14/2013
• Update in Hepatology 
  New Hanover Regional Medical Center, Wilmington, NC - 1/10/2013
• Review and Update in the Treatment of Hepatocellular Carcinoma: Triumphs and Pitfalls of Technology. 
  1/2/2013
• Liver Masses and Abdominal Imaging 
  Cape Fear Valley Medical Center - 1/31/2012
• Acute Liver Failure 
  Ruth’s Steakhouse, Cary - 1/25/2012
• Declining Quality of Donor Livers. Whither Transplant 
  1/24/2012
• Caring for the Cirrhotic Patient 
  New Hanover Regional Medical Center, Wilmington, NC - 1/12/2012
• When to Refer a Patient for Liver Transplantation 
  New Hanover Regional Medical Center, Wilmington, NC - 1/12/2012
• Acute Variceal Bleeding and Post-sclerotherapy Cerebral Embolism 
  1/9/2012
• Acute Liver Failure: Update 
  1/1/2012
• Rejection and Immunosuppression in Liver Transplantation. 
  1/27/2011
• Matching Donors to Recipients in Liver Transplantation 
  1/26/2011
• Hepatocellular Carcinom: Medical and Surgical Management 
  1/1/2011
• The Ethics of Transplanting Prisoners Convicted of Heinous Crimes 
  1/31/2010
• Case Conference: DILI Cases 
  1/30/2010
• Hepatocellular Carcinoma Diagnosis and Treatment. 
  Moses-Cone Hospital, Greensboro, NC - 1/21/2010
• Update on Management of Varices and Hyponatremia 
  1/20/2010
• Variceal Bleed Prevention and Treatment 
  1/18/2010
• Managing Advance Liver Disease 
  1/18/2010
• Ethics in Liver Transplantation 
  1/12/2010
• Hepatocellular Carcinoma: New Treatments 
  1/12/2010
• Hepatocellular Carcinoma: Effective Treatment 
  1/12/2009
• New Developments in Liver Transplantation and Acute Liver Failure 
  WakeMed Medical Center, Raleigh, NC - 1/11/2009
• Advances in the Management of Varices, Ascites and Encephalopathy 
  Pinehurst, NC - 1/7/2009
• Non-infectious Solid Liver Masses 
  University of North Carolina, Friday Center, NC - 1/26/2008
• Join now to see all